Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.

Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Abstract Text:

    d'nyce l williamsD'Nyce L Williams,daniel r newmanDaniel R Newman,susan a ballaghSusan A Ballagh,mitchell d creininMitchell D Creinin,kurt barnhartKurt Barnhart,debra h weinerDebra H Weiner,april j bellApril J Bell,denise j jamiesonDenise J Jamieson,d'nyce l williamsD'Nyce L Williams,daniel r newmanDaniel R Newman,susan a ballaghSusan A Ballagh,mitchell d creininMitchell D Creinin,kurt barnhartKurt Barnhart,debra h weinerDebra H Weiner,april j bellApril J Bell,denise j jamiesonDenise J Jamieson,

    OBJECTIVES: To assess the safety and acceptability of 2 vaginal microbicide gels (Acidform and BufferGel) used with a diaphragm compared to KY Jelly used with a diaphragm among low-risk, sexually abstinent women. STUDY DESIGN: Eighty-one women enrolled in a randomized, masked, phase I safety study using a diaphragm with Acidform, BufferGel, or KY Jelly for 6 to 10 hours nightly for 14 nights. Physical examination, colposcopy, and lab studies were performed after 1 and 2 weeks of use. Diaries and questionnaires were used to assess user acceptability. RESULTS: Sixty-nine participants (85%) completed the study. Safety and acceptability appeared similar among the 3 study groups and no serious adverse events related to the study products were reported. Adverse events were mild and anticipated. CONCLUSIONS: Acidform and BufferGel compared to KY Jelly, when used with diaphragm daily for 14 days, appeared to be safe and acceptable in a small study of low-risk abstinent women.

    Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Publishing Authors By Initials

    dl williamsDL Williams,dr newmanDR Newman,sa ballaghSA Ballagh,md creininMD Creinin,k barnhartK Barnhart,dh weinerDH Weiner,aj bellAJ Bell,dj jamiesonDJ Jamieson,dl williamsDL Williams,dr newmanDR Newman,sa ballaghSA Ballagh,md creininMD Creinin,k barnhartK Barnhart,dh weinerDH Weiner,aj bellAJ Bell,dj jamiesonDJ Jamieson,

    For similar bacterial infections and mycoses: bacterial infections: vaginosis, bacterial research abstracts see: bacterial infections and mycoses: bacterial infections: vaginosis, bacterial research

    PUBMED ID PMID:

    MEDLINE DATE:

    Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Sexually transmitted diseases

    VOLUME: 34

    Page Numbers: 977-84

    Journal Abbreviation:

    ISSN: 0148-5717

    DAY: 17

    MONTH: Dec

    YEAR: 2007

    Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7705941

    Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Keywords Mesh Terms:

    KEYWORDS: Vaginosis, Bacterial

    MESH TERMS: prevention & control

    Chemical & Substance for Abstract: Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Information

    Substance Name: Cellulose

    Registry Number: 9004-34-6

    Grant and Affiliation Information for Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.

    AFFILIATION: CONRAD, Arlington, VA, USA. dlw6@cdc.gov

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: MO1RR000056

    ACRONYM: RR

    MEDLINETA: Sex Transm Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Phase I safety trial of two vaginal microbicide gels Acidform or BufferGel used with a diaphragm compared to KY jelly used with a diaphragm Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News